8-K: Herbalife Q3 Net Sales Beat Guidance, North America Returns to Growth

Herbalife Ltd. reported third-quarter 2025 financial results, with net sales of $1.3 billion exceeding guidance and North America returning to year-over-year growth.

Summary

• Net sales for Q3 2025 were $1.3 billion, an increase of 2.7% year-over-year (3.2% on a constant currency basis), surpassing the midpoint of guidance.
• North America net sales increased by 1.0% year-over-year, marking the region's first quarterly gain since Q2 2021.
• Adjusted EBITDA for the quarter was $163.0 million, exceeding guidance, with a constant currency adjusted EBITDA of $175.1 million.
• Net income attributable to Herbalife was $43.2 million, and adjusted net income was $51.5 million.
• Diluted EPS was $0.42, with adjusted diluted EPS of $0.50, which included a $0.08 year-over-year foreign currency headwind.
• Net cash provided by operating activities for the quarter was $138.8 million.
• The company repaid $147.3 million of the remaining principal on its 2025 Notes, reducing the total leverage ratio to 2.8x as of September 30, 2025.
• Beta access to the Pro2col app was expanded to retail customers of the beta group on October 30, with enhanced features introduced.
• Full-year 2025 guidance ranges for net sales, adjusted EBITDA, and capital expenditures were tightened.

Sentiment

Score: 7

Explanation: The company delivered strong Q3 results, exceeding guidance for net sales and adjusted EBITDA, and achieved a significant milestone with North America returning to growth. Debt reduction and strategic investments in digital tools and new product lines are positive indicators. However, foreign currency headwinds and continued declines in China and Asia Pacific year-to-date temper the overall sentiment, suggesting a mixed but generally positive outlook.

Positives

• Net sales of $1.3 billion were above the midpoint of guidance range.
• Net sales increased 2.7% year-over-year (3.2% constant currency).
• North America net sales increased 1.0% year-over-year, marking the region's first quarterly gain since Q2 2021.
• Adjusted EBITDA of $163.0 million exceeded guidance.
• Net cash provided by operating activities was strong at $138.8 million for the quarter.
• Repaid $147.3 million of remaining principal on 2025 Notes, reducing total leverage ratio to 2.8x.
• Three of five regions reported year-over-year growth in new distributors, led by North America with a 17% increase.
• Worldwide new distributors increased 11% on a two-year stack basis.
• The Diamond Development Mastermind Program expanded to India and has approximately 10,700 participants.
• Extravaganza training events in 2025 attracted nearly 142,000 attendees, a 5% increase compared to 2024.
• Launched HL/Skin, a new skincare line combining South Korean science with K-beauty-formulated ingredients, supported by an AI-powered assessment tool.
• Expanded Pro2col app beta access and introduced new features, with planned commercial release by end of 2025 in U.S. and Puerto Rico.
• Full-year 2025 guidance ranges were tightened for net sales, adjusted EBITDA, and capital expenditures, indicating increased confidence.

Negatives

• Net sales included 50 basis points of foreign currency (FX) headwinds.
• Gross profit margin decreased to 77.7% in Q3 2025 from 78.3% in the prior year period, primarily due to 90 basis points of foreign currency headwinds, 30 basis points of input cost inflation, increased inventory write-downs, and unfavorable sales mix.
• Adjusted EBITDA margin decreased by 60 basis points year-over-year to 12.8%.
• Diluted EPS and adjusted diluted EPS included a $0.08 year-over-year foreign currency headwind.
• Worldwide new distributors declined 2% year-over-year in Q3 2025.
• China net sales declined (4.7)% year-over-year (4.8% constant currency) in Q3 2025 and (6.7)% year-to-date 2025.
• Asia Pacific net sales declined (1.2)% year-to-date 2025.
• North America net sales declined (2.4)% year-to-date 2025.

Risks

• Potential impacts of current global economic conditions, including inflation, unfavorable foreign exchange rate fluctuations, and tariffs or retaliatory tariffs, on the company, its Members, customers, supply chain, and the world economy.
• Ability to attract and retain Members.
• Relationship with, and ability to influence the actions of, Members.
• Noncompliance with, or improper action by employees or Members in violation of, applicable U.S. and foreign laws, rules, and regulations.
• Adverse publicity associated with the Company or the direct-selling industry, including the ability to comfort the marketplace and regulators regarding compliance with applicable laws.
• Changing consumer preferences and demands and evolving industry standards, including with respect to climate change, sustainability, and other environmental, social, and governance matters.
• The competitive nature of the business and industry.
• Legal and regulatory matters, including regulatory actions concerning, or legal challenges to, products or network marketing program and product liability claims.
• The Consent Order entered into with the Federal Trade Commission (FTC), the effects thereof and any failure to comply therewith.
• Risks associated with operating internationally and in China.
• Ability to execute growth and other strategic initiatives (such as restructuring efforts and increased market penetration in existing markets).
• The effectiveness and acceptance of new technology-driven initiatives.
• Any material disruption to the business caused by natural disasters, other catastrophic events, acts of war or terrorism (including the wars in Ukraine and the Middle East), cybersecurity incidents, pandemics, and/or other acts by third parties.
• Ability to adequately source ingredients, packaging materials, and other raw materials and manufacture and distribute products.
• Reliance on information technology infrastructure, and ability to successfully develop, deploy, and integrate artificial intelligence into the business.
• Noncompliance by the company or its Members with any privacy, artificial intelligence and data protection laws, rules, or regulations or any security breach involving the misappropriation, loss, or other unauthorized use or disclosure of confidential information.
• Contractual limitations on the ability to expand or change the direct-selling business model.
• The sufficiency of trademarks and other intellectual property.
• Product concentration.
• Reliance upon, or the loss or departure of any member of, the senior management team.
• Ability to integrate and capitalize on acquisition transactions.
• Restrictions imposed by covenants in the agreements governing indebtedness.
• Risks related to convertible notes.
• Changes in, and uncertainties relating to, the application of transfer pricing, income tax, customs duties, value added taxes, and other tax laws, treaties, and regulations, or their interpretation.
• Incorporation under the laws of the Cayman Islands.
• Share price volatility related to, among other things, speculative trading and certain traders shorting common shares.

Future Outlook

Herbalife provided guidance for the fourth quarter of 2025, projecting net sales growth of +1.5% to +5.5% year-over-year (or +0.5% to +4.5% constant currency) and Adjusted EBITDA between $144 million and $154 million. The full-year 2025 guidance was revised and tightened, with reported net sales now expected to be between (0.3)% and +0.7% year-over-year (compared to previous guidance of (1.0)% to +3.0%). Full-year Adjusted EBITDA is projected to be between $645 million and $655 million (previously $640 million to $660 million), and capital expenditures are expected to be $80 million to $90 million (previously $75 million to $95 million). The outlook includes preliminary estimates of the impact of incremental tariffs enacted as of November 4, 2025.

Management Comments

• "The third quarter demonstrated clear progress, with a return to growth in both North America and on a worldwide basis." John DeSimone, Chief Financial Officer.
• "We also further reduced our total leverage ratio to 2.8x, underscoring our continued capital discipline and outperformance against our capital structure commitments." John DeSimone, Chief Financial Officer.
• "Across our business, product innovation, digital evolution and disciplined execution are driving momentum and delivering results." Stephan Gratziani, Chief Executive Officer.
• "Through our transformation, we are equipping and supporting our distributors to grow stronger businessessupporting progress today and building a clear path to sustainable growth and long-term shareholder value." Stephan Gratziani, Chief Executive Officer.

Industry Context

The direct-selling industry, particularly in health and wellness, often faces challenges related to distributor recruitment and retention, regulatory scrutiny, and adapting to digital commerce. Herbalife's return to growth in North America and its focus on digital tools (Pro2col app) and product innovation (HL/Skin) suggest efforts to modernize its direct-selling model and address evolving consumer preferences, potentially differentiating itself in a competitive market. The expansion of training programs like the Diamond Development Mastermind also indicates a focus on strengthening its distributor network, a critical component of the direct-selling model. The company's performance, despite foreign currency headwinds, indicates resilience and strategic execution in a dynamic global market.

Comparison to Industry Standards

• The filing does not provide specific comparisons to other companies, industry benchmarks, or global standards for its financial results or operational performance.

Legal Proceedings

• General risks related to legal and regulatory matters, including regulatory actions concerning, or legal challenges to, products or network marketing program and product liability claims, and compliance with the Consent Order with the Federal Trade Commission (FTC), are noted in the forward-looking statements.

Stakeholder Impact

• Shareholders: Positive impact due to exceeding guidance, debt reduction, and tightened full-year outlook, potentially leading to increased shareholder value.
• Distributors: Positive impact from new digital tools (Pro2col app), product innovation (HL/Skin), and expanded training programs (Diamond Development Mastermind), which aim to support business growth and engagement.
• Customers: Benefit from expanded access to the Pro2col app and new product offerings like HL/Skin.
• Creditors: Positive impact from debt repayment and reduced leverage ratio.

Next Steps

• Commercial release of Pro2col Beta 2.0 to all customers and distributors in the U.S. and Puerto Rico by the end of 2025.
• Expansion of the Pro2col digital experience to additional global markets beginning in 2026.
• Expansion of the Diamond Development Mastermind Program to include additional markets in 2026.

Key Dates

Recommendation

While Herbalife demonstrated strong Q3 performance, exceeding guidance and achieving a return to growth in North America, the overall picture remains mixed. Foreign currency headwinds persist, and key markets like China continue to decline. The company's strategic initiatives in digital transformation and product innovation are promising, but their full impact on sustainable, widespread growth across all regions needs more time to materialize. The debt reduction is a positive, but the direct-selling model inherently carries specific risks, as highlighted in the filing. A "hold" recommendation allows investors to observe the continued execution of these strategies and their ability to drive consistent, broad-based growth before making a more definitive move.

Keywords

Herbalife, HLF, Q3 2025 Earnings, Financial Results, Net Sales, Adjusted EBITDA, Direct Selling, Nutrition, Health and Wellness, North America Growth, Pro2col App, Skincare, Debt Repayment, Guidance